Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2014 1
2015 1
2016 4
2017 3
2018 3
2019 7
2020 9
2021 11
2022 6
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Impact of prior antihypertensive treatment on COVID-19 outcomes, by active ingredient.
García-Álvarez RM, Zapata-Cachafeiro M, Visos-Varela I, Rodríguez-Fernández A, Pintos-Rodríguez S, Piñeiro-Lamas M, Herdeiro TM, Figueiras A, Salgado-Barreira A; COVID-Drug Group. García-Álvarez RM, et al. Among authors: salgado barreira a. Inflammopharmacology. 2024 Apr 15. doi: 10.1007/s10787-024-01475-2. Online ahead of print. Inflammopharmacology. 2024. PMID: 38619761
Outpatient antipsychotic use and severe COVID-19: avoiding the impact of age in a real-world data study.
Pintos-Rodríguez S, Visos-Varela I, Rodríguez Fernández A, Zapata-Cachafeiro M, Piñeiro-Lamas M, Herdeiro MT, García Álvarez RM, Figueiras A, Salgado-Barreira Á. Pintos-Rodríguez S, et al. Among authors: salgado barreira a. Int J Neuropsychopharmacol. 2024 Apr 11:pyae020. doi: 10.1093/ijnp/pyae020. Online ahead of print. Int J Neuropsychopharmacol. 2024. PMID: 38600711 Free article.
Impact of prior use of antiplatelets on COVID-19 susceptibility, progression, and severity: a population-based study.
Prieto-Campo Á, Zapata-Cachafeiro M, Portela-Romero M, Piñeiro-Lamas M, Figueiras A, Salgado-Barreira Á. Prieto-Campo Á, et al. Among authors: salgado barreira a. Rev Esp Cardiol (Engl Ed). 2024 Jan 6:S1885-5857(24)00014-8. doi: 10.1016/j.rec.2023.12.004. Online ahead of print. Rev Esp Cardiol (Engl Ed). 2024. PMID: 38191054 Free article. English, Spanish.
Protein Plasma Levels of the IGF Signalling System Are Altered in Major Depressive Disorder.
Fernández-Pereira C, Penedo MA, Rivera-Baltanás T, Pérez-Márquez T, Alves-Villar M, Fernández-Martínez R, Veiga C, Salgado-Barreira Á, Prieto-González JM, Ortolano S, Olivares JM, Agís-Balboa RC. Fernández-Pereira C, et al. Among authors: salgado barreira a. Int J Mol Sci. 2023 Oct 17;24(20):15254. doi: 10.3390/ijms242015254. Int J Mol Sci. 2023. PMID: 37894932 Free PMC article.
Effect of dapagliflozin on COVID-19 infection and risk of hospitalization.
Salgado-Barreira A, Seijas-Amigo J, Rodriguez-Mañero M, Piñeiro-Lamas M, Eiras S, Cordero A, Gonzalez-Juanatey JR, Figueiras A. Salgado-Barreira A, et al. J Antimicrob Chemother. 2023 Sep 5;78(9):2335-2342. doi: 10.1093/jac/dkad241. J Antimicrob Chemother. 2023. PMID: 37549309 Free PMC article.
Outpatient atorvastatin use and severe COVID-19 outcomes: A population-based study.
Visos-Varela I, Zapata-Cachafeiro M, Pintos-Rodríguez S, Bugarín-González R, González-Barcala FJ, Herdeiro MT, Piñeiro-Lamas M, Figueiras A, Salgado-Barreira Á. Visos-Varela I, et al. Among authors: salgado barreira a. J Med Virol. 2023 Jul;95(7):e28971. doi: 10.1002/jmv.28971. J Med Virol. 2023. PMID: 37486310
Differences in weight loss and safety between the glucagon-like peptide-1 receptor agonists: A non-randomized multicenter study from the titration phase.
Seijas-Amigo J, Salgado-Barreira Á, Castelo-Dominguez R, Pérez-Álvarez MT, Ponce-Piñón B, Fernández-Silva M, Rodríguez-Barreiro M, Pereira-Pía M, Iglesias-Moreno JM, Gago-García M, Montáns-García R, Fernandez-Perez A, FragaGayoso D, Fernandez-Montenegro M, Riveiro-Barciela B, Rilla-Villar N, Cordero A, RodríguezMañero M, González-Juanatey JR. Seijas-Amigo J, et al. Among authors: salgado barreira a. Prim Care Diabetes. 2023 Aug;17(4):366-372. doi: 10.1016/j.pcd.2023.05.004. Epub 2023 May 23. Prim Care Diabetes. 2023. PMID: 37230813 Free article.
Repurposing selective serotonin reuptake inhibitors for severity of COVID-19: A population-based study.
Visos-Varela I, Zapata-Cachafeiro M, Piñeiro-Lamas M, Carracedo-Martínez E, Saez M, Herdeiro MT, Figueiras A, Salgado-Barreira Á. Visos-Varela I, et al. Among authors: salgado barreira a. Eur Neuropsychopharmacol. 2023 Jun;71:96-108. doi: 10.1016/j.euroneuro.2023.03.011. Epub 2023 Apr 4. Eur Neuropsychopharmacol. 2023. PMID: 37094487 Free PMC article.
Colchicine and risk of hospitalization due to COVID-19: A population-based study.
Sáenz-Aldea M, Salgado-Barreira Á, Taracido Trunk M, Piñeiro-Lamas M, Herdeiro MT, Portela-Romero M, Saez M, Figueiras A. Sáenz-Aldea M, et al. Among authors: salgado barreira a. J Med Virol. 2023 Feb;95(2):e28496. doi: 10.1002/jmv.28496. J Med Virol. 2023. PMID: 36639903 Free PMC article.
48 results